Fund Twenty8: Smart Beta EIS fund for diversified early stage investing.
Location
Cambridge, Cambridgeshire, GB
Founded
2015
Fund Twenty8 is a Smart Beta EIS fund focused on early-stage investing across multiple sectors. The fund aims to provide investors with a diversified portfolio of startups, addressing the lack of sector diversification often seen in traditional EIS funds. Fund Twenty8 employs a passive investment strategy, allowing for a wide portfolio approach.
The fund is managed by SyndicateRoom, a prominent equity crowdfunding platform in the UK. Fund Twenty8's investment philosophy centers on spreading risk across various sectors and companies, offering investors exposure to a broad range of early-stage opportunities. One of its notable portfolio companies is Cambridge Nutraceuticals, which has raised $1,685,000 to date.
Fund Twenty8 - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
